{
    "eid": "2-s2.0-85135948078",
    "title": "Reimbursement Savings Associated With Tissue Versus Mechanical Surgical Aortic Valve Replacement in Thailand",
    "cover-date": "2022-11-01",
    "subject-areas": [
        {
            "@_fa": "true",
            "$": "Economics, Econometrics and Finance (miscellaneous)",
            "@code": "2001",
            "@abbrev": "ECON"
        },
        {
            "@_fa": "true",
            "$": "Pharmacology, Toxicology and Pharmaceutics (miscellaneous)",
            "@code": "3001",
            "@abbrev": "PHAR"
        },
        {
            "@_fa": "true",
            "$": "Health Policy",
            "@code": "2719",
            "@abbrev": "MEDI"
        }
    ],
    "keywords": [
        "health economics",
        "health systems policy",
        "reimbursement",
        "surgical aortic valve replacement"
    ],
    "authors": [
        "Chanapong Kittayarak",
        "Matt Reifenberger",
        "Sarah Chan",
        "Eric L. Keuffel"
    ],
    "citedby-count": 0,
    "ref-count": 43,
    "ref-list": [
        "Burden of valvular heart diseases: a population-based study",
        "Management of severe aortic stenosis: the Singapore and Asian perspective",
        "World population prospects 2019; Volume 1. United Nations",
        "World development indicators 2021. The World Bank",
        "2017 AHA/ACC focused update of the 2014 AHA/ACC guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. J Am Coll Cardiol",
        "Financial risk protection of Thailand's universal health coverage: results from series of national household surveys between 1996 and 2015",
        "Noninferiority of closely monitored mechanical valves to bioprostheses overshadowed by early mortality benefit in younger patients",
        "Very long-term outcomes of the Carpentier-Edwards Perimount valve in aortic position",
        "Very long-term outcomes of the Carpentier-Edwards Perimount aortic valve in patients aged 60 or younger",
        "Very long-term outcomes of the Carpentier-Edwards Perimount aortic valve in patients aged 50-65 years",
        "Prosthetic heart valve thrombosis",
        "Bioprosthetic aortic valve replacement in nonelderly adults: a systematic review, meta-analysis, and microsimulation",
        "Aortic valve replacement with mechanical vs. biological prostheses in patients aged 50-69 years",
        "Mechanical versus bioprosthetic aortic valve replacement in patients aged 50 years and younger",
        "National trends in utilization and in-hospital outcomes of mechanical versus bioprosthetic aortic valve replacements",
        "Hospital readmission rates are similar between patients with mechanical versus bioprosthetic aortic valves",
        "2017 AHA/ACC focused update of the 2014 AHA/ACC guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice guidelines",
        "Mechanical versus tissue aortic prosthesis in sexagenarians: comparison of hemodynamic and clinical outcomes",
        "Trends in hospitalizations and cost associated with stroke by age, United States 2003-2012",
        "Transcatheter aortic valve implantation within degenerated aortic surgical bioprostheses: PARTNER 2 Valve-in-Valve Registry",
        "Mechanical versus bioprosthetic aortic valve replacement in middle-aged adults: a systematic review and meta-analysis",
        "Long-term healthcare expenditures over time for tissue and mechanical aortic valve replacement",
        "Transferability of economic evaluations across jurisdictions: ISPOR Good Research Practices Task Force report",
        "Consolidated health economic evaluation reporting standards (CHEERS)\u2014explanation and elaboration: a report of the ISPOR health economic evaluation publication guidelines good reporting practices task force",
        "Cost-Effectiveness in Health and Medicine",
        "Long-term safety and effectiveness of mechanical versus biologic aortic valve prostheses in older patients: results from the Society of Thoracic Surgeons Adult Cardiac Surgery National Database",
        "Thai DRGs and Relative Weight, Version 5.1 Vol. 1. National Health Security Office (Thailand) Pages 199-209",
        "History of major bleeding predicts risk of clinical outcome of patients with atrial fibrillation: results from the COOL-AF registry",
        "Cost-effectiveness of pharmacist-participated warfarin therapy management in Thailand",
        "Final 5-year outcomes following aortic valve replacement with a RESILIA\u2122 tissue bioprosthesis",
        "A randomized assessment of an advanced tissue preservation technology in the juvenile sheep model",
        "Advanced integrity preservation technology reduces bioprosthesis calcification while preserving performance and safety",
        "Five-year outcomes of the COMMENCE trial investigating aortic valve replacement with a novel tissue bioprosthesis",
        "Time-driven activity-based cost analysis for outpatient anticoagulation therapy: direct costs in a primary care setting with optimal performance",
        "The economic burden of incident venous thromboembolism in the United States: a review of estimated attributable healthcare costs",
        "Thirty-day readmission after infective endocarditis: analysis from a nationwide readmission database",
        "90-day cost and clinical outcomes comparing TAVR to SAVR: do the economics work?",
        "Survival and long-term outcomes following bioprosthetic vs mechanical aortic valve replacement in patients aged 50 to 69 years",
        "Mechanical or biologic prostheses for aortic-valve and mitral-valve replacement",
        "Mechanical versus bioprosthetic valve replacement in middle-aged patients"
    ],
    "affiliation": [
        {
            "affiliation-city": "Irvine",
            "@id": "60086793",
            "affilname": "Edwards Lifesciences Corporation",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60086793",
            "affiliation-country": "United States"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "60028190",
            "affilname": "Chulalongkorn University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Singapore City",
            "@id": "128462886",
            "affilname": "Edwards Lifesciences",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/128462886",
            "affiliation-country": "Singapore"
        },
        {
            "affiliation-city": "Ardmore",
            "@id": "128462617",
            "affilname": "Health Finance &amp; Access Initiative",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/128462617",
            "affiliation-country": "United States"
        }
    ],
    "funding": [
        "Edwards Lifesciences"
    ]
}